These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 17289388)
1. Evaluation of the anti-hepatitis C virus effect of novel potent, selective, and orally bioavailable JNK and VEGFR kinase inhibitors. Raboisson P; Lenz O; Lin TI; Surleraux D; Chakravarty S; Scholliers A; Vermeiren K; Delouvroy F; Verbinnen T; Simmen K Bioorg Med Chem Lett; 2007 Apr; 17(7):1843-9. PubMed ID: 17289388 [TBL] [Abstract][Full Text] [Related]
2. Studies on acyl pyrrolidine inhibitors of HCV RNA-dependent RNA polymerase to identify a molecule with replicon antiviral activity. Burton G; Ku TW; Carr TJ; Kiesow T; Sarisky RT; Lin-Goerke J; Hofmann GA; Slater MJ; Haigh D; Dhanak D; Johnson VK; Parry NR; Thommes P Bioorg Med Chem Lett; 2007 Apr; 17(7):1930-3. PubMed ID: 17270443 [TBL] [Abstract][Full Text] [Related]
3. Effects of the aryl linker and the aromatic substituent on the anti-HCV activities of aryl diketoacid (ADK) analogues. Kim J; Kim KS; Lee HS; Park KS; Park SY; Kang SY; Lee SJ; Park HS; Kim DE; Chong Y Bioorg Med Chem Lett; 2008 Aug; 18(16):4661-5. PubMed ID: 18644717 [TBL] [Abstract][Full Text] [Related]
4. HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives. Wang G; Zhang L; Wu X; Das D; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Buckman BO; Kossen K; Seiwert SD; Beigelman L Bioorg Med Chem Lett; 2009 Aug; 19(15):4484-7. PubMed ID: 19497737 [TBL] [Abstract][Full Text] [Related]
5. HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives. Wang G; Lei H; Wang X; Das D; Hong J; Mackinnon CH; Coulter TS; Montalbetti CA; Mears R; Gai X; Bailey SE; Ruhrmund D; Hooi L; Misialek S; Rajagopalan PT; Cheng RK; Barker JJ; Felicetti B; Schönfeld DL; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L Bioorg Med Chem Lett; 2009 Aug; 19(15):4480-3. PubMed ID: 19500983 [TBL] [Abstract][Full Text] [Related]
6. HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives. Wang G; He Y; Sun J; Das D; Hu M; Huang J; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L Bioorg Med Chem Lett; 2009 Aug; 19(15):4476-9. PubMed ID: 19502055 [TBL] [Abstract][Full Text] [Related]
7. 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase. McGowan D; Nyanguile O; Cummings MD; Vendeville S; Vandyck K; Van den Broeck W; Boutton CW; De Bondt H; Quirynen L; Amssoms K; Bonfanti JF; Last S; Rombauts K; Tahri A; Hu L; Delouvroy F; Vermeiren K; Vandercruyssen G; Van der Helm L; Cleiren E; Mostmans W; Lory P; Pille G; Van Emelen K; Fanning G; Pauwels F; Lin TI; Simmen K; Raboisson P Bioorg Med Chem Lett; 2009 May; 19(9):2492-6. PubMed ID: 19342234 [TBL] [Abstract][Full Text] [Related]
9. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease. Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685 [TBL] [Abstract][Full Text] [Related]
10. 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase. Kumar DV; Rai R; Brameld KA; Riggs J; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Hu H; Lehoux I; Ho JD; Young WB; Hart B; Green MJ Bioorg Med Chem Lett; 2012 Jan; 22(1):300-4. PubMed ID: 22119470 [TBL] [Abstract][Full Text] [Related]
11. 6-Hydrazinopurine 2'-methyl ribonucleosides and their 5'-monophosphate prodrugs as potent hepatitis C virus inhibitors. Gunic E; Chow S; Rong F; Ramasamy K; Raney A; Li DY; Huang J; Hamatake RK; Hong Z; Girardet JL Bioorg Med Chem Lett; 2007 May; 17(9):2456-8. PubMed ID: 17331718 [TBL] [Abstract][Full Text] [Related]
12. Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives. Hutchinson DK; Rosenberg T; Klein LL; Bosse TD; Larson DP; He W; Jiang WW; Kati WM; Kohlbrenner WE; Liu Y; Masse SV; Middleton T; Molla A; Montgomery DA; Beno DW; Stewart KD; Stoll VS; Kempf DJ Bioorg Med Chem Lett; 2008 Jul; 18(14):3887-90. PubMed ID: 18599294 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors. Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Hsu TA; Yueh A; Chao YS; Chern JH Bioorg Med Chem Lett; 2009 Aug; 19(15):4134-8. PubMed ID: 19539472 [TBL] [Abstract][Full Text] [Related]
14. The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479). McGuigan C; Kelleher MR; Perrone P; Mulready S; Luoni G; Daverio F; Rajyaguru S; Le Pogam S; Najera I; Martin JA; Klumpp K; Smith DB Bioorg Med Chem Lett; 2009 Aug; 19(15):4250-4. PubMed ID: 19505826 [TBL] [Abstract][Full Text] [Related]